Rockwell Medical, Inc. Sustainability Profile
Rockwell Medical, Inc., a prominent player in the biopharmaceutical industry, is headquartered in the United States. Founded in 1996, the company has established itself as a leader in developing innovative therapies for patients with chronic kidney disease and end-stage renal disease. With a focus on dialysis and iron replacement therapies, Rockwell Medical offers unique products such as Triferic, which is designed to maintain iron levels in patients undergoing dialysis. The company operates primarily in North America, with a growing presence in international markets. Rockwell Medical's commitment to research and development has led to significant milestones, including FDA approvals and partnerships that enhance its market position. Recognised for its dedication to improving patient outcomes, Rockwell Medical continues to advance the field of renal care through its specialised offerings and innovative solutions.
DitchCarbon Score
How does Rockwell Medical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Rockwell Medical, Inc.'s score of 20 is lower than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Rockwell Medical, Inc.'s reported carbon emissions
Rockwell Medical, Inc., headquartered in the US, currently does not have available carbon emissions data, as indicated by the absence of specific figures in kg CO2e. The company has not outlined any formal reduction targets or commitments to the Science Based Targets initiative (SBTi) or other climate pledges. As there are no emissions data or reduction initiatives reported, it is unclear how Rockwell Medical, Inc. is addressing its carbon footprint or contributing to climate action within its industry. The lack of information suggests that the company may still be in the early stages of developing a comprehensive climate strategy.
How Carbon Intensive is Rockwell Medical, Inc.'s Industry?
How Carbon Intensive is Rockwell Medical, Inc.'s Location?
Rockwell Medical, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Rockwell Medical, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
